-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
West Pharmaceutical Services Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q4 2024.
- West Pharmaceutical Services Inc Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was $130M, a 5.04% decline year-over-year.
- West Pharmaceutical Services Inc Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was $493M, a 17% decline year-over-year.
- West Pharmaceutical Services Inc annual Net Income (Loss) Attributable to Parent for 2024 was $493M, a 17% decline from 2023.
- West Pharmaceutical Services Inc annual Net Income (Loss) Attributable to Parent for 2023 was $593M, a 1.28% increase from 2022.
- West Pharmaceutical Services Inc annual Net Income (Loss) Attributable to Parent for 2022 was $586M, a 11.5% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)